4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-24-000074
EVP, Chief Development Officer sold 7,338 shares at $50.42 ($369,960)
- EVP, Chief Development Officer acquired 19,852 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Geary Richard S · EVP, Chief Development Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-01-16 | Exercise or conversion : show line 1 in the form | +19,852 | 92,813 | D | ||
| 2024-01-17 | Sale : show line 2 in the form | −7,338 | $50.42 | $369,960 | 85,475 | D |
| Open-market sales · 7,338 sh · avg $50.42 · $369,960 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-01-16 | Exercise or conversion : show line 3 in the form Restricted Stock Unit | −19,852 | $0.00 | 19,852 | 46,625 | D |
Loading xslF345X05/edgardoc.xml…